SYNOPSIS: Caplin Point has acquired 10 approved ANDAs targeting a $473.2 million market, strengthening its US injectables and ophthalmic portfolio while paving the way for oncology launches and global ...
Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...
Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...
While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick a needle in their stomach on a weekly basis. Now, a potential game-changing ...
The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company’s original version of ...
Incog BioPharma, a sterile injectables CDMO, plans to shell out around $200 million to boost production capacity at its Fishers, Indiana, manufacturing site. The company expects the project to add ...
A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...
Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 receptor agonist, helps people maintain weight loss after switching from an injectable, Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback